Lifecore Biomedical, Inc.

NasdaqGS:LFCR

Sector

🛒 Consumer Staples

Industries

🏬 Consumer Packaged Goods

💄 Cosmetics

🏥 Hospitals & Clinics

🍔 Meat

🌱 Organic Foods

Location

United States

Market Cap

USD 273.62 M

Share Price

USD 7.39

Avg Daily Volume

276,490

Change (1 day)

6.48%

Change (1 year)

47.21%

Change (YTD)

-0.54%

Lifecore Biomedical, Inc. Revenue for the Trailing 12 Months (TTM) ending February 23, 2025: USD 130.31 M

Lifecore Biomedical, Inc. Revenue is USD 130.31 M for the Trailing 12 Months (TTM) ending February 23, 2025, a 6.88% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Lifecore Biomedical, Inc. Revenue for the Trailing 12 Months (TTM) ending February 25, 2024 was USD 121.92 M, a -12.53% change year over year.
Lifecore Biomedical, Inc. Revenue for the Trailing 12 Months (TTM) ending February 26, 2023 was USD 139.38 M, a -69.11% change year over year.
Lifecore Biomedical, Inc. Revenue for the Trailing 12 Months (TTM) ending February 28, 2022 was USD 451.19 M, a -19.50% change year over year.
Lifecore Biomedical, Inc. Revenue for the Trailing 12 Months (TTM) ending February 28, 2021 was USD 560.46 M, a -4.52% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

NasdaqGS: LFCR

Lifecore Biomedical, Inc.

CEO	Mr. Paul Josephs
IPO Date	Feb. 15, 1996
Location	United States
Headquarters	3515 Lyman Boulevard
Employees	524
Sector	🛒 Consumer Staples
Industries Consumer Packaged Goods 💄 Cosmetics 🏥 Hospitals & Clinics 🍔 Meat 🌱 Organic Foods

Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.